About AstraZeneca
AstraZeneca news and updates
Honeywell Ltd. partnered with AstraZeneca AG on Feb 22nd 22'.
Our collaboration with Honeywell demonstrates AstraZeneca's commitment to advancing sustainable healthcare innovation, with the aim of improving outcomes for patients while reducing our environmental footprint.
Jan 1, 2022 | news-journal.comAstraZeneca AG hired Johansson on Jan 1st 12'.
Johansson joined the Astra board in 2012, so he reached the normal term limit of nine years last year.
Jan 1, 2022 | morningstar.co.ukAstraZeneca AG partners with PAREXEL International Corporation
AstraZeneca in collaboration with Parexel is developing AZD8233 which is currently in Phase II of clinical trials.
Jan 1, 2022 | digitaljournal.comAstraZeneca AG launches Phase 3 results for PT027
AstraZeneca announced Phase 3 results for PT027, a potential first-in-class combination treatment for asthma.
Jan 1, 2021 | royaltypharma.comSophia Genetics partners with AstraZeneca AG
SOPHiA GENETICS is collaborating with AstraZeneca, aiming to expand access to in-house HRD testing across European laboratories and institutions.
Jan 1, 2022 | prnewswire.comAstraZeneca AG launches combination chemotherapy treatment improved radiographic progression-free survival compared to standard-of-care for metastatic castration-resistant prostate cancer patients
February 21, 2022 - AstraZeneca recently announced that its combination chemotherapy treatment improved radiographic progression-free survival (rPFS) compared to standard-of-care for metastatic castration-resistant prostate cancer (mCRPC) patients.
Jan 1, 2022 | pharmanewsintel.comAstraZeneca plc is developing next-generation respiratory inhalers using the propellant HFO-1234ze
AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.
Jan 1, 2022 | healthmatters.com.myAstraZeneca plc is developing investigational human monoclonal antibody
(Alliance News) - AstraZeneca PLC said on Tuesday its rare disease group has closed an exclusive ... (Alliance News) - AstraZeneca PLC said on Tuesday its rare disease group has closed an exclusive global collaboration to develop and commercialise an investigational human monoclonal antibody.
Jan 1, 2022 | morningstar.co.ukLeif Johansson retired from AstraZeneca plc as board on Mar 1st 22'.
AstraZeneca PLC said Tuesday that Nonexecutive Chairman Leif Johansson will retire from the board at the company's annual general meeting in 2023.
Jan 1, 2022 | marketwatch.comZyla partnered with AstraZeneca plc on Feb 28th 22'.
To enable the highest quality care at scale, Zyla has partnered with AstraZeneca to enable the Virtual Care Clinic (VCC)TM for more than 1400 doctor clinics.
Jan 1, 2022 | hindustantimes.comAstraZeneca plc partnered with Jireh Group on May 22nd 21'.
In Malaysia, AstraZeneca recently collaborated with GetDoc to drive awareness and impart new insights on asthma care to doctors and healthcare professionals, in addition to community outreach.
Jan 1, 2021 | jirehgroup.asiaAstraZeneca plc partners with Unicef Nl
AstraZeneca is working with UNICEF in an effort that taps young leaders to lead the way in curbing noncommunicable diseases such as cancer and diabetes.
Jan 1, 2020 | fiercepharma.comAstraZeneca plc partners with World Heart Federation
Major pharma company AstraZeneca has signed a new partnership with the World Heart Federation (WHF) in an effort to reduce the global burden of cardiovascular diseases.
Jan 1, 2020 | epmmagazine.comInteb Managed Services Ltd. will partner with AstraZeneca plc on Mar 11th 22'.
A SPECIALIST team from environmental experts Inteb has begun a collaboration with global biopharmaceutical company AstraZeneca to work on its programme to achieve zero carbon emissions.
Jan 1, 2021 | weareinteb.co.ukAshfield Health, LLC partners with AstraZeneca plc
The award recognised a team effort between the SEC and global healthcare events specialist, Ashfield Meetings & Events, in partnership with AstraZeneca for their inspirational Annual Fast Start Conference, held last year.
Jan 1, 2019 | sec.co.ukAstraZeneca plc is developing potential treatment NI006
AstraZeneca, through its rare disease division Alexion, has signed an exclusive global collaboration and licence deal with Swiss firm Neurimmune to develop the latter’s potential treatment NI006.
Jan 1, 2022 | ns-healthcare.comAstraZeneca plc is developing eplontersen enables Ionis
Its collaboration with AstraZeneca to jointly develop and commercialize eplontersen enables Ionis to potentially maximize benefit for patients, bolster its commercial organization and accelerate preparations for its near-term product launches.
Jan 1, 2022 | ionispharma.comOuisoc partners with AstraZeneca plc
For example, Oxford University partnered with AstraZeneca Inc., providing large amounts of data and research to a corporation with many pharmaceutical ties.
Jan 1, 2022 | miselectronics.comAstraZeneca plc acquired Kadmon Holdings, Inc. on Sep 8th 21'.
On September 8, 2021, Kadmon Holdings, Inc. agreed to be acquired by AstraZeneca plc for $9.50 per share in cash.
Jan 1, 2021 | bioshares.comAstraZeneca plc is developing NI006
AstraZeneca and Neuroimmune have closed an exclusive global collaboration and license agreement to develop and commercialize NI006.
Jan 1, 2022 | pharmtech.comAstraZeneca plc recognized as top employer in Kenya under the pharmaceuticals category
AstraZeneca pharmaceutical company has been named the top employer in Kenya under the pharmaceuticals category by the Top Employers institute alongside Novartis, a world leader in the research and development of products.
Jan 1, 2022 | marketscreener.comAstraZeneca plc is developing Covid vaccine on Apr 1st 20'.
It was the month of April 2020 and a statement from the Jenner Institute at Oxford University announced a partnership with pharmaceutical giant AstraZeneca to develop a Covid vaccine.
Jan 1, 2022 | scroll.inAstraZeneca plc launches health and well-being app Health Gate
AstraZeneca has launched its health and well-being app Health Gate to support patients with chronic conditions such as cancer, heart failure, kidney disease, and diabetes.
Jan 1, 2022 | arabianbusiness.comPATH partners with AstraZeneca plc
PATH is pleased to partner with AstraZeneca and Qure.ai to scale the use of AI for broader lung health screening and accelerate linkages to diagnosis to improve treatment outcomes and quality of care.”
Jan 1, 2022 | path.orgAstraZeneca plc is developing drugs for CKD and idiopathic pulmonary fibrosis on Jan 1st 19'.
In 2019, BenevolentAI and AstraZeneca entered a strategic collaboration aiming to discover new drugs for CKD and idiopathic pulmonary fibrosis (IPF).
Jan 1, 2021 | biospace.comTARIS Biomedical LLC partnered with AstraZeneca plc on Mar 8th 22'.
TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has entered into a research collaboration with AstraZeneca to evaluate novel treatments for bladder cancer.
Jan 1, 2022 | nordiclifescience.orgAstraZeneca plc partners with Swiss Government
AstraZeneca has entered into an agreement with the Swiss Government to supply 5’000 doses of tixagevimab and cilgavimab, a long-acting antibody (LAAB) combination for the prevention of COVID-19.
Jan 1, 2022 | astrazeneca.chAstraZeneca plc launches Health Gate
AstraZeneca has launched its all-in-one health and wellbeing patient support app, Health Gate, aimed at supporting patients with chronic conditions, such as cancer, heart failure, kidney disease and diabetes.
Jan 1, 2022 | dubaihealthcareguide.comAstraZeneca plc is developing Evusheld
For patients like me, AstraZeneca has developed a product called Evusheld.
Jan 1, 2022 | morethanlupus.comAstraZeneca plc launched R&D Postdoctoral Challenge on Mar 17th 22'.
AstraZeneca today launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases.
Jan 1, 2022 | astrazeneca.comAstraZeneca plc launched Accelerating Change Together for Cancer Care on Mar 21st 22'.
Earlier this month, at the postponed Expo 2020 Dubai, AstraZeneca launched Accelerating Change Together (ACT) for Cancer Care, a global coalition to advance cancer treatment and diagnosis worldwide.
Jan 1, 2022 | scidev.netAstraZeneca plc launched report on the WUSM study on Mar 21st 22'.
AstraZeneca published a report on the WUSM study on Monday.
Jan 1, 2022 | dailyhive.comAstraZeneca plc recognized as Fast Track Designation in the United States
AstraZeneca has been granted Fast Track Designation in the United States (US) for the development of LOKELMA ® (sodium zirconium cyclosilicate) to reduce arrhythmia-related cardiovascular outcomes in patients on chronic hemodialysis with recurrent hyperkalemia (HK).
Jan 1, 2022 | healthokayplease.comBristol-Myers Squibb Company files suit against AstraZeneca plc
Bristol-Myers Squibb ( NYSE: BMY ) has filed a patent infringement lawsuit against AstraZeneca ( NASDAQ: AZN ) that argues that the U.K.-based pharma's cancer treatment Imfinzi (durvalumab) infringes on patents related to Opdivo (nivolumab).
Jan 1, 2022 | seekingalpha.comAstraZeneca plc is developing Ultomiris for generalised myasthaenia gravis and neuromyelitis optica spectrum disorder
AstraZeneca and Alexion are in the process of developing Ultomiris for generalised myasthaenia gravis and neuromyelitis optica spectrum disorder, while also working to produce a new subcutaneous formulation of the medicine which would give patients the ability to administer it themselves, rather than having to have an intravenous treatment at a clinic or hospital.
Jan 1, 2022 | pmlive.comAstraZeneca plc launches Software as a Medical Device
As part of this partnership, Huma and AstraZeneca will launch Software as a Medical Device (SaMD) companion apps targeted at several therapeutic areas and will partner to help accelerate adoption of decentralized clinical trials.
Jan 1, 2022 | prnewswire.comAstraZeneca plc launches companion apps using SaMD
As part of the partnership between the two UK companies, Huma and AstraZeneca will launch companion apps using SaMD.
Jan 1, 2022 | endpts.comAstraZeneca plc partners with Circular Bioeconomy Alliance
AstraZeneca has announced a partnership with the Circular Bioeconomy Alliance (CBA) and local partners to establish the first ‘Living Lab’ in Ghana.
Jan 1, 2022 | african.businessAstraZeneca plc receives financing of $40M in series A funding
used by industry leaders University of Sydney, AstraZeneca and American Express — has raised $40 million in series A funding to shake up the consultancy sector.
Jan 1, 2022 | smartcompany.com.auAstraZeneca plc launches AMAZE chronic disease management platform
AstraZeneca has developed the AMAZE chronic disease management platform to enhance the care of patients.
Jan 1, 2022 | nsmedicaldevices.comAstraZeneca plc invested into assets : research and development facility in the amount of $1B on Dec 1st 21'.
And in December 2021, AstraZeneca unveiled a $1 billion state-of-the-art research and development facility to advance next-generation therapeutics, including nucleotide-based gene-editing and cell therapies.
Jan 1, 2022 | pharmanewsintel.comAstraZeneca plc invested into assets : manufacturing facility in the amount of $360M in Ireland on Mar 27th 21'.
Last year, AstraZeneca announced it would invest $360m in a new manufacturing facility in Ireland, creating 100 jobs.
Jan 1, 2022 | independent.ieAstraZeneca plc acquires Huma Therapeutics
AstraZeneca has bought a stake in digital health firm Huma Therapeutics in a deal that will see ownership of AZ’s AMAZE disease management platform transfer to the UK startup.
Jan 1, 2022 | pharmaphorum.comAstraZeneca plc is developing next-generation respiratory inhalers using the propellant HFO-1234ze
AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.
Jan 1, 2022 | bangkokpost.comAstraZeneca plc launched Evusheld long-acting monoclonal antibody on Mar 28th 22'.
U.K.-based AstraZeneca PLC today announced its Evusheld long-acting monoclonal antibody (mAbs) combination had been approved in the European Union.
Jan 1, 2022 | precisionvaccinations.comAstraZeneca plc acquired Ardea Inc. on Nov 9th 17'.
Under the terms of the agreement, AstraZeneca will acquire Ardea for $32 per share which represents a total cash value of approximately $1.26 billion.
Jan 1, 2017 | fiercebiotech.comAstraZeneca plc launches Brilinta
Global pharmaceutical company AstraZeneca has announced its drug Brilinta (ticagrelor) in combination with aspirin has met its primary endpoint, a statistically significant reduction in major adverse cardiovascular events, in the Phase III THEMIS trial.
Jan 1, 2019 | pharmaceutical-technology.comAstraZeneca plc launches vaccine benefiting three billion people
Oxford University and AstraZeneca jointly rolled out a vaccine benefiting three billion people.
Jan 1, 2022 | businessweekly.co.ukAstraZeneca plc invested into assets : facility in the amount of $190M on Jan 1st 13'.
In 2013 AstraZeneca plc announced plans to invest $190 million to construct a new facility to continue production of Zoladex.
Jan 1, 2022 | astrazeneca.comAstraZeneca plc launches flagship sustainability programme Ambition Zero Carbon
Since AstraZeneca plc launched its flagship sustainability programme Ambition Zero Carbon, the devastation caused by COVID-19 has led to extraordinary changes across the world.
Jan 1, 2022 | astrazeneca.comAstraZeneca plc is developing therapies for cardiovascular, metabolic and renal diseases on Jan 1st 15'.
ION449 was born out of a pact between Ionis (then named Isis Pharmaceuticals) and AstraZeneca made in 2015 to develop therapies for cardiovascular, metabolic and renal diseases.
Jan 1, 2022 | fiercebiotech.comHarbour Biomed partners with AstraZeneca plc
Harbour BioMed (“HBM”, “the Company”, HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, today announced a global out-license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CLDN18.2xCD3 bispecific antibody (HBM7022), a novel bispecific antibody generated from HBM’s HCAb Based Immune Cell Engagers (HBICE ® ) Platform.
Jan 1, 2022 | harbourbiomed.comEmergent BioSolutions partners with AstraZeneca plc
Emergent (NYSE: EBS) was a manufacturing partner with both Johnson & Johnson (NYSE: JNJ) and AstraZeneca (NASDAQ: AZN) on Covid-19 vaccines.
Jan 1, 2021 | bizjournals.comAstraZeneca plc is developing tralokinumab and tezepelumab
In addition to Fasenra, AstraZeneca is developing tralokinumab and tezepelumab, which the British company believes can together form a leading biologics portfolio in respiratory.
Jan 1, 2017 | biopharmadive.comIdeaevolver partners with AstraZeneca plc
Idea Evolver partnered with AstraZeneca to build a medical device software product using Google Cloud products and services.
Jan 1, 2022 | azalio.ioIdeaevolver partners with AstraZeneca plc
Idea Evolver partnered with AstraZeneca to build a medical device software product using Google Cloud products and services.
Jan 1, 2022 | azalio.ioIchor Medical Systems Inc. partnered with AstraZeneca plc on Mar 26th 19'.
Ichor Medical Systems has entered into a collaboration and research license agreement with AstraZeneca (NYSE: AZN ) for the development and clinical assessment of plasmid DNA constructs.
Jan 1, 2019 | seekingalpha.comAstraZeneca plc is developing combination therapy of GI-101 and Imfinzi
GI Innovation said it has entered a clinical collaboration agreement with AstraZeneca to develop a combination therapy of GI-101 and Imfinzi.
Jan 1, 2021 | koreabiomed.comAstraZeneca plc launches Healthy Lung Taskforces in India
The Healthy Lung Programme was established in 2017, when AstraZeneca and governmental, medical and academic partners launched Healthy Lung Taskforces in India, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.
Jan 1, 2019 | yahoo.comAstraZeneca plc is developing therapies for multiple cancer types
He told BioSpace that after years of academic research focused on the tumor profiles of patients, he wants to close out his career by helping AstraZeneca develop new therapies for multiple cancer types.
Jan 1, 2022 | biospace.comAstraZeneca plc receives financing of $100M in round of financing
a joint venture between state-owned SDIC Fund Management, Swedish drug maker AstraZeneca and Zytz Partners – has announced the completion of a $100-million round of financing led by Lilly Asia Ventures (LAV).
Jan 1, 2020 | dealstreetasia.comAstraZeneca plc closes offices in Waltham, Massachusetts, United States
As part of the move, AstraZeneca plans to close a research site in Waltham, with employees transferring to the new Kendall office.
Jan 1, 2022 | bizjournals.comAstraZeneca plc expands facilities to Frederick, Maryland, United States
Major pharmaceutical manufacturer, AstraZeneca, wished to add a dining and conference facility to their existing 400,000-square-foot vaccine production plant in Frederick, Maryland.
Jan 1, 2022 | noelkerhull.comAstraZeneca plc launched 7th annual sustainability report on Mar 25th 22'.
AstraZeneca recently released its 7th annual sustainability report, focused heavily on issues such as access to healthcare, environmental protection, and ethics and transparency strategy.
Jan 1, 2022 | businessinsider.comAstraZeneca plc partners with Sanofi Genzyme
AstraZeneca has also teamed up with Sanofi in the hopes of producing a vaccine, which would help the company recoup lost revenue.
Jan 1, 2022 | ukinvestormagazine.co.ukAstraZeneca plc partners with Forestry England
The government has pledged to plant 30,000 hectares of woodland a year by 2024; AstraZeneca has partnered with Forestry England to plant a million trees across the UK, including restoring native woodland in southern Scotland; the National Trust aims to have 20m new trees on trust land by 2030.
Jan 1, 2022 | theguardian.comAstraZeneca plc partners with Sanofi Genzyme
AstraZeneca has also teamed up with Sanofi in the hopes of producing a vaccine, which would help the company recoup lost revenue.
Jan 1, 2022 | ukinvestormagazine.co.ukAstraZeneca plc launches Be You
AstraZeneca and Amgen have launched "Be You," their first branded DTC ad for new severe asthma med Tezspire.
Jan 1, 2022 | fiercepharma.comAstraZeneca plc partnered with Thermo Fisher Scientific on Apr 18th 21'.
AstraZeneca, meanwhile, teamed up with Thermo Fisher Scientific late last year with a global, multiyear agreement for companion diagnostics across its precision medicine pipelines.
Jan 1, 2022 | fiercebiotech.comAstraZeneca plc files suit against Kindeva Drug Delivery
Having secured the patient, AstraZeneca filed an ANDA action against Mylan and Kindeva in the District Court asserting patent infringement.
Jan 1, 2022 | fiercepharma.comAmoy Diagnostics Co. Ltd partnered with AstraZeneca plc on Apr 1st 22'.
In April 2022, Amoy Diagnostics has entered into master collaboration agreement with AstraZeneca for the development and commercialization of AmoyDx assays that may cover any type of indication or biomarker for companion diagnostic (CDx) use with AstraZeneca medicines globally.
Jan 1, 2022 | biospace.comAstraZeneca plc expands offices in Massachusetts, United States
New Haven officials and biotechnology sector experts say AstraZeneca’s plan to expand its footprint in Massachusetts is not expected to impact the company’s Alexion Pharmaceuticals presence in Connecticut.
Jan 1, 2022 | greenwichtime.comAstraZeneca plc recognized as top IBD 50 Stocks to Watch
AstraZeneca ( AZN ) is one of the top IBD 50 Stocks to Watch, thanks to strong growth projections and outperformance in its sector.
Jan 1, 2022 | investors.comSumitomo Pharma partnered with AstraZeneca plc on Dec 26th 16'.
Sumitomo Dainippon Pharma already announced that it has entered into an agreement with AstraZeneca to conduct meropenem business in five South-east Asian countries and Hong Kong, on December 26, 2016.
Jan 1, 2017 | ds-pharma.comAstraZeneca plc receives award Business of the Year
Meanwhile, AstraZeneca took home the Business of the Year award – a recognition of the decision to sell their life-saving Covid-19 vaccine at cost price.
Jan 1, 2022 | cityam.comAstraZeneca plc is developing antibody therapy that could vaccinate newborns to prevent RSV disease
In addition to the vaccines, Sanofi and AstraZeneca are working on an antibody therapy that could vaccinate newborns to prevent RSV disease.
Jan 1, 2022 | biospace.comAstraZeneca plc acquired Kudospharma for $210M on Jan 1st 05'.
AstraZeneca said in its suit that it acquired exclusive rights to develop and sell commercialized products that use olaparib when it bought KuDOS Pharmaceuticals Ltd. ,. . . In the legal profession, information is the key to success.
Jan 1, 2020 | law360.comAstraZeneca plc opened new location in Cambridge, Massachusetts, United States on Apr 29th 22'.
LONDON: AstraZeneca has announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub.
Jan 1, 2022 | newsnreleases.comAstraZeneca plc invested into assets : research and development facility in the amount of $1B on Dec 1st 21'.
In December 2021, AstraZeneca unveiled a $1 billion state-of-the-art research and development facility to advance next-generation therapeutics, including nucleotide-based gene-editing and cell therapies.
Jan 1, 2022 | pharmanewsintel.comAstraZeneca plc launches Vaxzevria is struggling to gain traction
AstraZeneca's newly launched Vaxzevria is struggling to gain traction.
Jan 1, 2022 | fool.comAstraZeneca plc partners with Loftware, Inc.
AstraZeneca, a global leader in pharmaceuticals, worked with Loftware to upgrade its Artwork Management solution in order to support the company’s corporate strategy, ensure business continuity, and minimize risk.
Jan 1, 2022 | loftware.comAstraZeneca plc launched data on Farxiga on May 5th 22'.
AstraZeneca Thursday also released new data on Farxiga (dapaglifloxzin) for reducing the risk of death or heart failure.
Jan 1, 2022 | seekingalpha.comAstraZeneca plc is developing therapeutics for heart failure
AstraZeneca and Moderna have also partnered to develop new therapeutics for heart failure, and are currently plugging away at a potential mRNA treatment.
Jan 1, 2022 | fiercebiotech.comAstraZeneca plc launches DTC campaign for newly approved systemic lupus drug Saphnelo
AstraZeneca has rolled out its first DTC campaign for newly approved systemic lupus drug Saphnelo.
Jan 1, 2022 | fiercepharma.comAstraZeneca plc recognized as European Union
Drugmaker AstraZeneca on Monday its COVID-19 vaccine, Vaxzevria, has been approved in the European Union by the region’s medical regulator as a third-dose booster in adults following a panel recommendation last week.
Jan 1, 2022 | whbl.comAstraZeneca plc had issues with infringement of eight patents related to anti-PD-L1 antibodies on Mar 17th 22'.
BMS filed its complaint against AstraZeneca on March 17, 2022, alleging infringement of eight patents related to anti-PD-L1 antibodies.
Jan 1, 2022 | mondaq.comAstraZeneca plc is developing mAbs against SARS-CoV-2
The UK-based biotech company RQ Biotechnology Ltd (RQ Bio), which focuses on developing mAbs for therapeutic and preventative medicines, has agreed that AstraZeneca has the exclusive worldwide licence to develop, manufacture and commercialise their suite of mAbs against SARS-CoV-2.
Jan 1, 2022 | europeanpharmaceuticalreview.comAstraZeneca plc recognized as UK-Malaysia Partnership of the Year
Meanwhile, AstraZeneca and Sunway University were named as UK-Malaysia Partnership of the Year in recognition of the former’s agenda to drive digital innovation in healthcare via their partnership with the latter.
Jan 1, 2022 | theedgemarkets.comAstraZeneca plc launches clinical data for bispecific PD1-CTLA4 antibody MEDI5752
AstraZeneca plc is also excited to share promising clinical data for its bispecific PD1-CTLA4 antibody MEDI5752 in advanced renal cell carcinoma, designed to have both of these clinically validated checkpoint targets in one molecule, delivering efficacy with an improved tolerability profile.”
Jan 1, 2022 | astrazeneca.comAstraZeneca plc partners with Boston Properties Inc.
AstraZeneca is partnering with Boston Properties to create a 570,000-sf R&D center in Cambridge, Mass.
Jan 1, 2022 | tradelineinc.comAstraZeneca plc invests into assets : facility in the amount of $1.26B
The AstraZeneca £1bn facility will support the company's focus on specialised and precision medicine as well as the development of next-generation therapeutics.
Jan 1, 2022 | lucyfrazer.org.ukWheadon retired from AstraZeneca plc as Senior Vice President, Global Regulatory Affairs, Patient Safety and Quality Assurance on Jan 1st 19'.
Dr. Wheadon retired from AstraZeneca PLC in 2019 as Senior Vice President, Global Regulatory Affairs, Patient Safety and Quality Assurance, a position he had held since 2014.
Jan 1, 2022 | marketscreener.comAstraZeneca plc is developing Covid antibodies worldwide
(Alliance News) - AstraZeneca PLC on Tuesday said it signed a license agreement with RQ ... (Alliance News) - AstraZeneca PLC on Tuesday said it signed a license agreement with RQ Biotechnology Ltd to develop, manufacture and sell Covid antibodies worldwide.
Jan 1, 2022 | morningstar.co.ukAstraZeneca plc launches Enhertu
Astrazeneca has just announced a new breast cancer drug, Enhertu.
Jan 1, 2021 | portfolio-adviser.comAstraZeneca plc is developing novel drug delivery device for kidney on Jan 1st 19'.
In January 2019, AstraZeneca collaborated with Aptamer Group, a biotechnology company for exploring its technology to develop a novel drug delivery device for kidney.
Jan 1, 2022 | tgbbj.comIllumina, Inc. partnered with AstraZeneca plc on Jun 2nd 22'.
Illumina ( NASDAQ: ILMN ) unit GRAIL on Thursday announced a collaboration with AstraZeneca ( AZN ) to make and sell companion diagnostic assays for use with AZN's therapies.
Jan 1, 2022 | seekingalpha.comPascal leaves AstraZeneca plc as chief operating officer
Sir Pascal, who has been chief executive at AstraZeneca since 2012, served as chief operating officer of Roche’s pharmaceuticals division from 2010 to September 2012, and before that he was chief executive officer of Genentech, a biologics business, where he led its merger with Roche.
Jan 1, 2022 | newschainonline.comAstraZeneca plc is developing COVID-19 antibodies and Novavax
In other COVID news, AstraZeneca enters an agreement to develop COVID-19 antibodies and Novavax files for emergency use authorization of its COVID-19 vaccine in Taiwan.
Jan 1, 2022 | pharmanewsintel.comImperial College London partners with AstraZeneca plc
Imperial College London is partnering with AstraZeneca to lay the foundations for new medical breakthroughs and publications in leading journals.
Jan 1, 2021 | imperial.ac.ukAstraZeneca plc launched Evusheld on Nov 27th 21'.
Luckily for Nadeem-Baker and people like her, AstraZeneca has developed an injectable drug called Evusheld that would give her the coronavirus antibodies she’s missing.
Jan 1, 2021 | latimes.comAstraZeneca plc is developing CDx for BRCA gene mutations in breast cancer patients
In the EU, AmoyDx and AstraZeneca are partnering to develop CDx for BRCA gene mutations in breast cancer patients.
Jan 1, 2022 | art25capital.comAstraZeneca plc launches NICE recommendation of Imfinzi for routine use within NHS England
AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the treatment of locally advanced stage III unresectable non-small-cell lung cancer (NSCLC).
Jan 1, 2022 | pharmafile.comAstraZeneca plc invested into assets : manufacturing facility in the amount of $360M in Dublin, County Dublin, Ireland on Jun 24th 21'.
The announcement follows on from last year’s news that AstraZeneca was planning a $360m investment in a new manufacturing facility at the Alexion campus in Blanchardstown, in a move that would create 100 new jobs.
Jan 1, 2022 | siliconrepublic.comAstraZeneca plc receives award BioIT World Innovative Practice Award at Bio-IT World Conference
AstraZeneca’s drug design program built using AWS wins innovation award – AstraZeneca received the BioIT World Innovative Practice Award at the 20th anniversary of the Bio-IT World Conference for its novel augmented drug design platform built on AWS.
Jan 1, 2022 | amazon.comAstraZeneca plc launches fleet of Mobile Vaccination Clinics
In an effort to shield last-mile communities from the pandemic, Amref Health Africa and AstraZeneca are introducing a fleet of Mobile Vaccination Clinics (MVCs) in partnership with the Ministry of Health (MoH) in Kenya.
Jan 1, 2022 | hhmglobal.comAstraZeneca plc is developing HBM7022 CLDN18.2xCD3 bispecific antibody developed using HBM’s HCAb based Immune Cell Engagers platform for the treatment of solid tumors, including gastric and pancreatic cancer
Harbour BioMed granted AstraZeneca exclusive, worldwide rights to develop and commercialize its HBM7022 CLDN18.2xCD3 bispecific antibody developed using HBM’s HCAb based Immune Cell Engagers (HBICE) platform for the treatment of solid tumors, including gastric and pancreatic cancer.
Jan 1, 2022 | dealforma.comAstraZeneca plc recognized as Greater Toronto Area Top Employer
Headquartered in Mississauga, Ontario, AstraZeneca has been recognized as a Greater Toronto Area Top Employer for eight straight years.
Jan 1, 2022 | europeanhealtheconomics.comAstraZeneca plc launched Break the Cycle’ on Jan 1st 22'.
At the beginning of 2022, AstraZeneca and Amgen launched an unbranded influencer campaign dubbed ‘Break the Cycle’ as part of their strategy for the asthma drug Tezspire.
Jan 1, 2022 | eradigm.comAstraZeneca plc is developing digital solution on Jul 5th 22'.
BAAR, SWITZERLAND, July 5, 2022 / EINPresswire.com / -- AstraZeneca has signed a cooperation agreement with the Swiss-Israeli startup company docdok.health to develop a new digital solution that can monitor patients’ asthma status in real-time, identifying situations in which asthma may worsen and sending immediate alerts to the treating physician.
Jan 1, 2022 | einnews.comAstraZeneca plc partners with Accord Healthcare Inc
Plaintiffs have failed to allege that AstraZeneca’s purported pay-for-delay agreement with Accord Healthcare harmed competition in the market for psychiatric medication Seroquel XR, a federal court has ruled.
Jan 1, 2022 | globalcompetitionreview.comOXB partnered with AstraZeneca plc on Nov 7th 20'.
More positively, Oxford Biomedica shares rose on a new Covid-19 vaccine deal with AstraZeneca.
Jan 1, 2022 | shareprices.comAstraZeneca plc is developing digital patient management programme for chronic kidney disease patients in Taiwan
The latest partner is AstraZeneca, which has signed up with Health2Sync to develop a digital patient management programme for chronic kidney disease (CKD) patients in Taiwan.
Jan 1, 2022 | pharmaphorum.comAstraZeneca plc launches Learning Academy
AstraZeneca have unveiled a pioneering new Learning Academy at the Macclesfield Campus.
Jan 1, 2022 | davidrutley.org.ukAstraZeneca plc hired Joanna Loizou on Jul 15th 22'.
Joanna Loizou, one of the Principal Investigators who helped establish CeMM from 2011 to 2020, is leaving Vienna to join AstraZeneca.
Jan 1, 2022 | cemm.atAstraZeneca plc launches website
AstraZeneca has launched a new website with educational materials and says it is working closely with patient and professional groups to inform patients and health care providers.
Jan 1, 2022 | webmd.comAstraZeneca plc hired Michel Demare as chairman-designate of the board on Jul 29th 22'.
AstraZeneca PLC said Friday that its independent nonexecutive director and chairman of the company's remuneration committee Michel Demare has been appointed as the new chairman-designate of the board.
Jan 1, 2022 | marketscreener.comAstraZeneca plc launched Healthy Heart Africa on Aug 4th 22'.
AstraZeneca, the Federal Government of Nigeria through the National Primary Health Care Development Agency (NPHCDA), and Population Services International (PSI) on Thursday launched the Healthy Heart Africa (HHA) programme.
Jan 1, 2022 | latestnigeriannews.comAstraZeneca plc launches BeyondBio SCALE
Pharmaceutical company AstraZeneca, consulting firm Accenture, Amazon Web Services, and Israeli health organization Clalit Health Services have together launched a new startup program called BeyondBio SCALE to enhance the growth of Israel's digital health sector.
Jan 1, 2022 | calcalistech.comAstraZeneca plc will partner with National Primary Health Care Development Agency on Aug 11th 22'.
AstraZeneca, in collaboration with the National Primary Health Care Development Agency (NPHCDA) and the Population Services International (PSI) Nigeria, Thursday launched a programme to prevent and control hypertension in the country.
Jan 1, 2022 | dailytrust.comThorne Research Inc. partnered with AstraZeneca plc on Aug 4th 22'.
Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN ), a leader in developing innovative solutions for a personalized approach to health and wellness, today announced a two-year continuation of the collaboration with AstraZeneca, a leading biopharmaceuticals company.
Jan 1, 2022 | prnewswire.comWuXi Biologics partners with AstraZeneca plc
Shares of Chinese contract research, development and manufacturing organization (CRDMO) WuXi Biologics (HK: 2269) rose more than 5% yesterday, after the Chinese vaccine maker said it is partnering with AstraZeneca (LSE: AZN) to produce the UK pharma major’s COVID-19 preventive drug, that was approved by Chinese regulatory authorities last month, according to a report by Yicai Global.
Jan 1, 2022 | thepharmaletter.comAstraZeneca plc launched industrial park for metabolic diseases on Aug 5th 22'.
AstraZeneca releases its new industrial park for metabolic diseases and management in the Wuxi National High-tech District on Aug 5.
Jan 1, 2022 | wuxinews.com.cnAstraZeneca plc is developing TNB-486 as a potential new medicine for B-cell haematologic malignancies
1 AstraZeneca will develop TNB-486 as a potential new medicine for B-cell haematologic malignancies.
Jan 1, 2022 | astrazeneca.comAstraZeneca plc hires Wayra as Innovation Partner
Wayra joins AstraZeneca as an Innovation Partner to promote innovative initiatives in the health sector Through this alliance, Wayra will provide AstraZeneca with access to the entrepreneurial ecosystem and its network of investors while identifying startups whose solutions can be applied to the main health challenges to which the pharmaceutical company wants to contribute.
Jan 1, 2022 | centivis.comAstraZeneca plc launches Phase Ib trial of datopotamab deruxtecan and pembrolizumab
Daiichi Sankyo, AstraZeneca, and Merck previously conducted a Phase Ib trial of datopotamab deruxtecan and pembrolizumab with or without chemotherapy in patients with advanced or metastatic NSCLC.
Jan 1, 2021 | precisiononcologynews.comAdherium Limited signed new client AstraZeneca plc on Jan 1st 21'.
Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that it has been awarded a contract for supply of the Hailie® solution to an upcoming US-based clinical study by AstraZeneca.
Aug 16, 2022 | biosciencemanagers.comAstraZeneca plc is developing COVID-19 vaccine on Mar 20th 20'.
Early in the pandemic, in the spring of 2020, AstraZeneca partnered with the University of Oxford to develop a COVID-19 vaccine.
Aug 24, 2022 | biospace.comAstraZeneca plc partners with Health
In an effort to protect hard-to-reach communities from the COVID-19 pandemic, Amref Health Africa and AstraZeneca, in partnership with Kenya’s Ministry of Health (MoH) are set to launch 10 Mobile Vaccination Clinics (MVCs) to increase access to COVID-19 vaccines and other health services across the country.
Jun 27, 2022 | scienceafrica.co.keAstraZeneca plc is developing novel companion diagnostic assay for Lynparza
AstraZeneca has entered into a definitive agreement with Foundation Medicine, Inc. (Foundation Medicine) to develop a novel companion diagnostic assay for Lynparza (olaparib) to support its global development programme.
Sep 12, 2022 | nordiclifescience.orgAstraZeneca plc acquires Achillion Pharmaceuticals, Inc.
AstraZeneca acquired the drug through its 2020 purchase of Alexion Pharmaceuticals, which had itself bought the medicine via a 2019 deal for Achillion Pharmaceuticals.
Sep 16, 2022 | biopharmadive.comAstraZeneca plc is developing Beyfortus
Sanofi and AstraZeneca are jointly developing Beyfortus.
Sep 17, 2022 | worldpharmatoday.comAstraZeneca plc launched Up The Antibodies on Sep 15th 22'.
WILMINGTON, Del.--( BUSINESS WIRE )--Today, AstraZeneca (Nasdaq: AZN) launched Up The Antibodies, an important new campaign that embraces the reality for millions of immunocompromised Americans 1,2 : COVID-19 isn’t over.
Sep 15, 2022 | businesswire.comKjell Jorner leaves AstraZeneca plc
Dr. Kjell Jorner joins the team from AstraZeneca, as an affiliated postdoc researcher while stationed in Toronto.
Jan 6, 2021 | rahmlab.comRenalytix AI plc partnered with AstraZeneca plc on Aug 21st 20'.
RenalytixAI collaborates with AstraZeneca for chronic kidney disease.
Aug 20, 2020 | seekingalpha.comAstraZeneca plc receives award BWB Award
PINC AI™ Applied Sciences, AstraZeneca and Clinithink win BWB Award for innovative use of technology-enabled healthcare solutions in Digital Medicine.
Sep 25, 2022 | premierinc.comAstraZeneca plc acquires LogicBio Therapeutics, Inc.
AstraZeneca plc (Nasdaq: AZN) is buying LogicBio Therapeutics Inc. (Nasdaq: LOGC) for $2.07 per share, a 660% premium that values the total acquisition at $68 million.
Sep 30, 2022 | yahoo.comAstraZeneca plc recognized as granted marketing authorisation in Great Britain
AstraZeneca’s (AZ) Tezspire (tezepelumab) has been granted marketing authorisation in Great Britain by the Medicines and Healthcare products Regulatory Agency (MHRA) for use as an add-on maintenance treatment for patients 12 years and older with severe asthma, the company announced.
Sep 27, 2022 | pmlive.comAstraZeneca plc launched Severe Asthma awareness campaign entitled, ‘Listen To Your Asthma on Oct 7th 22'.
AstraZeneca announced today the launch of its Severe Asthma awareness campaign entitled, ‘Listen To Your Asthma’, in collaboration with Asthma Malaysia and Brand Ambassador Dina Nadzir, singer and radio announcer, sharing her personal journey as an asthma patient.
Oct 6, 2022 | healthmatters.com.myAstraZeneca plc recognized as BWB Awards winner for innovative use of technology-enabled healthcare solutions in the Digital Medicine category
PINC AI ™ Applied Sciences (PAS) and AstraZeneca, along with their partner Clinithink, have been chosen as the BWB Awards winner for innovative use of technology-enabled healthcare solutions in the Digital Medicine category.
Sep 29, 2022 | premierinc.comPlan International partners with AstraZeneca plc
For the 10 th anniversary of International Day of the Girl, Plan USA is partnering with AstraZeneca, Smartly.io, and Vertex, to host these Takeovers.
Oct 10, 2022 | planusa.orgAstraZeneca plc has issues with industry codes of practices
AstraZeneca has provided input into the article content and reviewed for medical accuracy and compliance with industry codes of practices.
Oct 10, 2022 | patient.infoAstraZeneca plc acquired Spirogen for $440M on Jan 1st 13'.
Management is headed by CEO Christopher Martin, who has been with the firm since its formation and was previously CEO of Spirogen, which was acquired by AstraZeneca in 2013.
Feb 12, 2020 | thestreet.comMirati Therapeutics, Inc. partnered with AstraZeneca plc on Oct 19th 22'.
THE-349 is a fourth-generation, potent and selective, small molecule designed to inhibit all major classes of EGFR activating and resistance mutations... Clinical collaboration with AstraZeneca announced for the evaluation of osimertinib in combination with IK-930 for patients with EGFR-mutant lung cancers... (RTTNews) - Oncology company Mirati Therapeutics, Inc. (MRTX) and biopharmaceutical company Aadi Bioscience, Inc. (AADI) announced Wednesday a clinical...
Oct 19, 2022 | userwalls.newsIkena Oncology Inc partnered with AstraZeneca plc on Oct 18th 22'.
Ikena also announced a clinical trial collaboration agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for the evaluation of TAGRISSO ® (osimertinib), a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in combination with Ikena’s IK-930 as treatment for patients with EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC).
Oct 18, 2022 | globenewswire.comAstraZeneca plc partnered with Riverlane Ltd on Oct 17th 21'.
Combining AstraZeneca’s domain expertise in drug discovery with Riverlane’s expertise in quantum computing, the two companies have partnered for the past year to delve more deeply into quantum computing’s potential in informing drug discovery.
Oct 16, 2022 | riverlane.comAstraZeneca plc is developing successor drug to Soliris and Ultomiris
AstraZeneca is developing a successor drug to Soliris and Ultomiris, as well as a trio of oral compounds that target another protein called factor D.
Oct 24, 2022 | biopharmadive.comInvitae Corporation partnered with AstraZeneca plc on Oct 27th 22'.
Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to use Invitae's Ciitizen natural history data in a retrospective and prospective study of patients diagnosed with cholangiocarcinoma, a rare bile duct cancer.
Oct 26, 2022 | biospace.comAstraZeneca plc expands facilities to Ireland
Earlier this summer, meanwhile, AstraZeneca said it was pouring another 65 million euros into its next-generation manufacturing plant in Dublin, plus another Alexion plant in Ireland 120 kilometers west in Athlone.
Oct 24, 2022 | fiercepharma.comAstraZeneca plc partners with Baheya
In Egypt, AstraZeneca has partnered with Baheya Foundation ( https://Baheya.org ) to promote BRCA testing for women in order to improve early diagnosis and patient outcomes and has already reached 700,000 women with awareness initiatives.
Oct 27, 2019 | newsprobeng.comAstraZeneca plc launches OOH campaign
AstraZeneca has released an OOH campaign across Dubai's roads to raise awareness of the early symptoms and the screening criteria for lung cancer, as part of the overarching “United Against Lung Cancer” program, under the major tagline of “HOPE Over Fear”.
Dec 9, 2021 | insiteooh.comAstraZeneca plc recognized as industry leader in Product Delivery
AstraZeneca was recognised by AtMI as the industry leader in Product Delivery, noting its application of tailored access strategies for different countries reflecting their income classifications across all product categories.
Nov 15, 2022 | astrazeneca.comAstraZeneca plc is developing PT027
November 18, 2022 - AstraZeneca and Avillion recently teamed up to develop PT027, an asthma rescue inhaler.
Nov 17, 2022 | pharmanewsintel.comAstraZeneca plc is developing monoclonal antibody treatment
AstraZeneca and Sanofi are jointly working on a monoclonal antibody treatment that could be given to infants and children to prevent severe disease.
Nov 18, 2022 | yahoo.comAstraZeneca plc acquired Neogene Therapeutics, Inc. for $320M on Jan 1st 22'.
AstraZeneca’s acquisition of Neogene is its third biotech buyout this year, expanding its capabilities in cell therapy, gene editing and bispecific antibodies.
Nov 9, 2022 | biopharmadive.comAstraZeneca plc recognized as Best Place to Work in Indonesia for 2022 on Oct 24th 22'.
AstraZeneca Indonesia, a ffiliate of the multinational pharmaceutical and biopharmaceutical company, was recently recognized as the Best Place to Work in Indonesia for 2022.
Nov 24, 2022 | yahoo.comAstraZeneca plc is developing treatments for CKD and IPF on May 1st 19'.
In May 2019, AstraZeneca partnered with BenevolentAI to develop treatments for CKD and IPF.
Nov 26, 2022 | pharmaceutical-technology.comAstraZeneca plc partners with Oncoshot Pte Ltd
AstraZeneca worked with Oncoshot on its patient-to-trial matching technology, for example, while it also collaborated with Gendius on its CKD screening algorithm.
Nov 22, 2022 | businesscloud.co.ukAstraZeneca plc recognized as finalist for 'Excellence in Learning and Development at 10 th annual edition of HR Excellence Awards on Jan 1st 22'.
At the 10 th annual edition of HR Excellence Awards, Singapore in 2022, AstraZeneca Singapore was handpicked as a finalist for 'Excellence in Learning and Development'.
Nov 28, 2022 | humanresourcesonline.netC4X Discovery Holdings PLC partners with AstraZeneca plc
C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, has signed an exclusive worldwide licensing agreement with AstraZeneca worth up to $402 million 1, for its NRF2 Activator programme.
Nov 28, 2022 | gurufocus.comAstraZeneca plc is developing oral treatment for chronic obstructive pulmonary disease
C4X Discovery Holdings and AstraZeneca have entered into a licensing agreement to develop an oral treatment for chronic obstructive pulmonary disease (COPD) and other inflammatory and respiratory illnesses.
Nov 28, 2022 | contractpharma.comAstraZeneca plc is developing C4XD
AstraZeneca will develop and commercialize an oral therapy, C4XD.
Nov 28, 2022 | labiotech.euAstraZeneca plc acquires C4X Discovery Holdings PLC
Coming off the back of its announcement yesterday that it was acquiring C4X Discovery for $402m, AstraZeneca this morning announced it was acquiring Neogene Therapeutics for $320m.
Nov 29, 2022 | cmcmarkets.comOslo Cancer Cluster partnered with AstraZeneca plc on Oct 1st 22'.
Oslo Cancer Cluster and the SPARK Norway programme at University of Oslo both signed a memorandum of understanding with AstraZeneca in October 2022.
Dec 1, 2022 | marketscreener.comAstraZeneca plc sold assets to Resilience Technology Corporation on Dec 1st 22'.
In separate news, AstraZeneca has announced it is selling its West Chester site in Ohio, USA, to California-based biopharma manufacturer National Resilience.
Nov 30, 2022 | chemanager-online.comAstraZeneca plc hired Nicola on Jan 1st 98'.
Nicola joined AstraZeneca in 1998 as a medicinal chemist.
Dec 9, 2022 | tinnitus.org.ukAstraZeneca plc launches campaign for clot-fighter Brilinta
AstraZeneca launched a new campaign for its clot-fighter Brilinta with patients who note they are survivors, not victims.
Dec 10, 2022 | fiercepharma.comResilience Technology Corporation partnered with AstraZeneca plc on Nov 29th 22'.
On Nov. 29, Resilience announced it had entered into a long-term biomanufacturing agreement with pharmaceutical giant AstraZeneca (AZ) that includes Resilience purchasing and operating AZ’s manufacturing facility in West Chester, Ohio.
Dec 13, 2022 | sdbj.comAstraZeneca plc is developing evidence-informed policy recommendations
That’s why AstraZeneca partnered with the London School of Economics and the World Economic Forum early in the pandemic to create the Partnership for Health System Sustainability and Resilience (PHSSR), a global collaboration between academic, non-governmental, life sciences, health care and business organizations to develop evidence-informed policy recommendations that will improve the sustainability and resilience of health care systems in a post-COVID world.
Dec 7, 2022 | theglobeandmail.comAstraZeneca plc partners with G42 Healthcare
Advanced medicines and pharmaceuticals will be manufactured in Abu Dhabi, following an agreement between AstraZeneca and the A.I.-powered healthcare company, G42 Healthcare.
Dec 11, 2022 | radioshoma934.aeAlmac Group Inc. partnered with AstraZeneca plc on Jun 23rd 22'.
Almac will work with AstraZeneca to provide novel treatments to patients in places with significant unmet medical needs.
Jun 23, 2022 | yahoo.comAlmac Group Inc. partnered with AstraZeneca plc on Jun 23rd 22'.
Almac will work with AstraZeneca to provide novel treatments to patients in places with significant unmet medical needs.
Jun 23, 2022 | yahoo.comAstraZeneca plc launches Get Real
Hoping to facilitate conversations between patients and their healthcare providers, AstraZeneca has unveiled “Get Real,” a campaign marketing chronic obstructive pulmonary disease inhaler Breztri Aerosphere.
Feb 23, 2021 | mmm-online.comAstraZeneca plc is developing vaccines and therapies for protection
Multinational pharmaceutical and biotechnology company AstraZeneca is committed to develop vaccines and therapies for protection, in collaboration with Latin American countries, as well as educational institutions for the spread of validated scientific information, officials told News is my Business.
Dec 29, 2022 | newsismybusiness.com